Free Trial

Avacta Group (LON:AVCT) Stock Passes Below 200-Day Moving Average - What's Next?

Avacta Group logo with Medical background

Avacta Group Plc (LON:AVCT - Get Free Report) shares crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 42.91 ($0.58) and traded as low as GBX 31 ($0.42). Avacta Group shares last traded at GBX 32.34 ($0.44), with a volume of 702,896 shares changing hands.

Avacta Group Price Performance

The company has a debt-to-equity ratio of 52.53, a current ratio of 1.29 and a quick ratio of 4.96. The stock's fifty day moving average is GBX 35.13 and its 200-day moving average is GBX 42.32. The stock has a market cap of £104.48 million, a PE ratio of -3.54 and a beta of 1.12.

About Avacta Group

(Get Free Report)

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics. The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US. Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).

See Also

Should You Invest $1,000 in Avacta Group Right Now?

Before you consider Avacta Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avacta Group wasn't on the list.

While Avacta Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines